Tag Archives: Defy

Vanda on Rehearing: Will the Federal Circuit Defy SCOTUS?

by Dennis Crouch Vanda Pharms. Inc. v. West-Ward Pharms. Int’l Ltd., 887 F.3d 1117 (Fed. Cir. 2018) offers an example of a claim on the cusp of eligibility.  In a 2-1 decision, Vanda’s schizophrenia treatment claim was found eligible with … Continue reading

Posted in Intellectual Property | Tagged , , , , , | Leave a comment